Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture Combined With Dexmedetomidine for Post-stroke Depression Prevention
NCT07739329Phase 4Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Dec 2026
01
Overview
A Phase 4 trial of dexmedetomidine in major depressive disorder (MDD). Planned start Aug 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07739329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739329.